Patent · US Expired

Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use

US7517520B2 · kind B2 · utility

44Cited by
29References
50Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 25, 2004
Grant dateApr 14, 2009
Priority date
Expiry dateJun 23, 2024

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the finding that virus like particles (VLPs) can be loaded with immunostimulatory substances, in particular with DNA oligonucleotides containing non-methylated C and G (CpGs). Such CpG-VLPs are dramatically more immunogenic than their CpG-free counterparts and induce enhanced B and T cell responses. The immune response against antigens optionally coupled, fused or attached otherwise to the VLPs is similarly enhanced as the immune response against the VLP itself. In addition, the T cell responses against both the VLPs and antigens are especially directed to the Th1 type. Antigens attached to CpG-loaded VLPs may therefore be ideal vaccines for prophylactic or therapeutic vaccination against allergies, tumors and other self-molecules and chronic viral diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.